Geographic variation in systemic treatment of metastatic pancreatic adenocarcinoma (mPAC) patients in real world across Europe

被引：0
|
作者：
Taieb, J. [1 ]
Carrato, A. [2 ]
AMellbring [3 ]
Prager, G. [4 ]
Melisi, D. [5 ]
Westphalen, B. [6 ]
Macarulla Mercade, T. [7 ,8 ]
D'Esquermes, N. [9 ]
Ferreras, A. [10 ]
De Jong, F. [11 ]
机构：
[1] Paris Descartes Univ, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, Paris, France
[2] Alcala Univ, Hosp Univ Ramon Y Cajal, CIBERONC, IRYCIS, Madrid, Spain
[3] Shire Sweden AB, Kista, Sweden
[4] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Med 1, Clin Div Med Oncol, Vienna, Austria
[5] Univ Verona, Med Oncol, Verona, Italy
[6] Klinikum Univ Munchen, Comprehens Canc Ctr Munchen, Munich, Germany
[7] Vall dHebron Univ Hosp, Barcelona, Spain
[8] Vall dHebron Inst Oncol, Barcelona, Spain
[9] Genactis, Chateauneuf, France
[10] Genactis, Antibes, France
[11] Shire Int GmbH, Glattpark Opfikon, Switzerland
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O - 002
引用
收藏
页码：100 / +
页数：2
相关论文
共 50 条
  • [31] Real-world treatment and outcomes of frontline chemotherapy in patients with metastatic pancreatic cancer.
    Al Mutar, Salwan
    Beg, Muhammad Shaalan
    Hansen, Eric
    Belli, Andrew J.
    Vaz, Maegan
    Velamoor, Sudhakar
    He, Ming
    Wang, Ching-Kun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] A phase I/II study of ribociclib plus everolimus in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) refractory to chemotherapy.
    Weinberg, Benjamin Adam
    Wang, Hongkun
    Witkiewicz, Agnieszka Katarzyna
    Marshall, John
    Knudsen, Erik S.
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] REAL-WORLD TREATMENT PATTERNS AND TREATMENT SEQUENCES IN THE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER SETTINGS ACROSS EUROPE
    Castro, E.
    Orji, C.
    Ribbands, A.
    Butcher, J.
    Walley, M.
    Li, W.
    Ghate, S.
    VALUE IN HEALTH, 2024, 27 (06) : S227 - S227
  • [34] First-line (1L) full dose (f) and modified (m) FOLFIRINOX and gemcitabine plus nab-paclitaxel (GN) treatment (tx) for metastatic pancreatic adenocarcinoma (mPAC) patients (pts) in routine clinical practice across Europe
    Taieb, J.
    Carrato, A.
    Westphalen, B.
    Melisi, D.
    Prager, G.
    Macarulla Mercade, T.
    Mellbring, A. B. C.
    d'Esquermes, N.
    Ferreras, A.
    de Jong, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Real-world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real-world data project
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Ohtani, Keiko
    Shinozaki, Nobuaki
    Minami, Hironobu
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (06)
  • [36] Real world antipsychotic prescribing patterns for schizophrenia treatment across Europe
    Locklear, J.
    Perry, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S447 - S447
  • [37] Real world hospital costs associated with nab-paclitaxel plus gemcitabine (nab-P plus G) and FOLFIRINOX (FFX) as first line (1 L) treatment (tx) for metastatic pancreatic adenocarcinoma (MPAC).
    Kim, George P.
    Parisi, Monika
    Patel, Manish
    Belk, Kathy
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] First and second-line palliative systemic treatment outcomes in a real-world metastatic pancreatic cancer cohort
    Pijnappel, E.
    Dijksterhuis, W. P. M.
    van der Geest, L.
    de vos-Geelen, J.
    de Groot, J. W. B.
    ten Tije, A. J.
    Homs, M.
    Creemers, G-J.
    Mohammad, N. Haj
    van Laarhoven, H. W. M.
    Wilmink, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S939 - S940
  • [39] KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma
    Norton, Carter
    Shaw, Matthew Steven
    Rubnitz, Zachary
    Smith, Jarrod
    Soares, Heloisa P.
    Nevala-Plagemann, Christopher D.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JAMA NETWORK OPEN, 2025, 8 (01)
  • [40] Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.
    Miotke, Laura
    Nevala-Plagemann, Christopher Duane
    Ying, Jian
    Florou, Vaia
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
12345